Staple Pharmaceuticals currently exports to over 86 countries and 5 continents globally which include North America, CIS, Latin America, Africa and South-East Asia. With over 380 International Product Registrations (still expanding), we are emerging as a major potential Indian Pharmaceuticals manufacturer.

Streamlining the export vision at Staple Pharmaceuticals a dedicated Export regulatory department team has been set up for complying with international audits and providing complete export documentation including COPP and dossier preparations as per CTD format. Operating in total compliance with c-GMP norms, Staple Pharmaceuticals manufacturing unit has been granted certifications by many regulatory Agencies.

WHO-GMP/GMP/COA/ As Required By Client

We endeavor to become the world class pharmaceutical manufacturer for India & neighboring countries and to assist in the development of quality products by providing superior performance with high Quality products in right budget. Our formulation development team and regulatory department are focused on bringing latest generics to our markets thereby guaranteeing a constant flow of the latest products to our customers.

Our Branded and Generic medicines enjoy steady demand in following countries:

Asia	Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan
Africa	South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast
North & Latin America	USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador
Europe	Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia
OCEANIA	Australia, New Zealand, Fiji